Cargando…
Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer
Ovarian cancer (OVC) is one of the most difficult types of cancer to detect in the early stages of its development. There have been numerous attempts to identify a biomarker for OVC; however, an accurate diagnostic marker has yet to be identified. The present study profiled OVC candidate metabolites...
Autores principales: | KIM, SEUNG CHEOL, KIM, MIN KYUNG, KIM, YUN HWAN, AHN, SUN-A, KIM, KYUNG-HEE, KIM, KUN, KIM, WON KI, LEE, JUN HWA, CHO, JAE YOUL, YOO, BYONG CHUL |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081284/ https://www.ncbi.nlm.nih.gov/pubmed/25013471 http://dx.doi.org/10.3892/ol.2014.2214 |
Ejemplares similares
-
Low-mass-ion discriminant equation (LOME) for ovarian cancer screening
por: Lee, Jun Hwa, et al.
Publicado: (2016) -
Reduced levels of N’-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival
por: Kim, Kyung-Hee, et al.
Publicado: (2017) -
Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer
por: Lee, Jun Hwa, et al.
Publicado: (2018) -
Diagnosis and mortality prediction of sepsis via lysophosphatidylcholine 16:0 measured by MALDI-TOF MS
por: Lee, Eun Hye, et al.
Publicado: (2020) -
Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
por: Lee, Y. K., et al.
Publicado: (1999)